These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15363661)

  • 61. Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime.
    Lin J; Cashman JR
    Chem Res Toxicol; 1997 Aug; 10(8):842-52. PubMed ID: 9282832
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative analysis of FMO gene mRNA levels in human tissues.
    Zhang J; Cashman JR
    Drug Metab Dispos; 2006 Jan; 34(1):19-26. PubMed ID: 16183778
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nitric oxide-related species-induced protein oxidation: reversible, irreversible, and protective effects on enzyme function of papain.
    Väänänen AJ; Kankuri E; Rauhala P
    Free Radic Biol Med; 2005 Apr; 38(8):1102-11. PubMed ID: 15780768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quinuclidine
    Shimizu M; Makiguchi M; Uno Y; Yamazaki H
    Drug Metab Dispos; 2024 Jul; 52(8):906-910. PubMed ID: 38769015
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Flavin monooxygenase metabolism: why medicinal chemists should matter.
    Cruciani G; Valeri A; Goracci L; Pellegrino RM; Buonerba F; Baroni M
    J Med Chem; 2014 Jul; 57(14):6183-96. PubMed ID: 25003501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes.
    Henderson MC; Siddens LK; Morré JT; Krueger SK; Williams DE
    Toxicol Appl Pharmacol; 2008 Dec; 233(3):420-7. PubMed ID: 18930751
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase.
    Uehara S; Shimizu M; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2017 May; 45(5):497-500. PubMed ID: 28258069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine.
    Cashman JR; Park SB; Yang ZC; Washington CB; Gomez DY; Giacomini KM; Brett CM
    Drug Metab Dispos; 1993; 21(4):587-97. PubMed ID: 8104117
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Population-specific polymorphisms of the human FMO3 gene: significance for detoxication.
    Cashman JR; Akerman BR; Forrest SM; Treacy EP
    Drug Metab Dispos; 2000 Feb; 28(2):169-73. PubMed ID: 10640514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Potential for drug interactions mediated by polymorphic flavin-containing monooxygenase 3 in human livers.
    Shimizu M; Shiraishi A; Sato A; Nagashima S; Yamazaki H
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):70-4. PubMed ID: 25760532
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities.
    Yamazaki H; Shimizu M
    Biochem Pharmacol; 2013 Jun; 85(11):1588-93. PubMed ID: 23567996
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans.
    Cashman JR; Park SB; Berkman CE; Cashman LE
    Chem Biol Interact; 1995 Apr; 96(1):33-46. PubMed ID: 7720103
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differential mechanisms underlying the modulation of delayed-rectifier K+ channel in mouse neocortical neurons by nitric oxide.
    Han NL; Ye JS; Yu AC; Sheu FS
    J Neurophysiol; 2006 Apr; 95(4):2167-78. PubMed ID: 16421196
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
    Yamazaki H; Fujita H; Gunji T; Zhang J; Kamataki T; Cashman JR; Shimizu M
    Mol Genet Metab; 2007 Jan; 90(1):58-63. PubMed ID: 16996766
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A genetic analysis of nitrosative stress.
    Foster MW; Liu L; Zeng M; Hess DT; Stamler JS
    Biochemistry; 2009 Feb; 48(4):792-9. PubMed ID: 19138101
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantification of Flavin-containing Monooxygenases 1, 3, and 5 in Human Liver Microsomes by UPLC-MRM-Based Targeted Quantitative Proteomics and Its Application to the Study of Ontogeny.
    Chen Y; Zane NR; Thakker DR; Wang MZ
    Drug Metab Dispos; 2016 Jul; 44(7):975-83. PubMed ID: 26839369
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5.
    Zhang J; Cerny MA; Lawson M; Mosadeghi R; Cashman JR
    J Biochem Mol Toxicol; 2007; 21(4):206-15. PubMed ID: 17721934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Na+,K+-ATPase activity is inhibited in cultured intestinal epithelial cells by endotoxin or nitric oxide.
    Suzuki Y; Lu Q; Xu DZ; Szabó C; Haskó G; Deitch EA
    Int J Mol Med; 2005 May; 15(5):871-7. PubMed ID: 15806312
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trimethylaminuria and a human FMO3 mutation database.
    Hernandez D; Addou S; Lee D; Orengo C; Shephard EA; Phillips IR
    Hum Mutat; 2003 Sep; 22(3):209-13. PubMed ID: 12938085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.